Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678

por Snobre, J., Villellas, M. C., Coeck, N., Mulders, W., Tzfadia, O., de Jong, B. C., Andries, K., Rigouts, L.
Publicado 2023

Multidrug-resistant tuberculosis in prison inmates, Azerbaijan.

por Pfyffer, G E, Strässle, A, van Gorkum, T, Portaels, F, Rigouts, L, Mathieu, C, Mirzoyev, F, Traore, H, van Embden, J D
Publicado 2001

Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations

por Rigouts, L., Miotto, P., Schats, M., Lempens, P., Cabibbe, A. M., Galbiati, S., Lampasona, V., de Rijk, P., Cirillo, D. M., de Jong, B. C.
Publicado 2019

The Repetitive Element RLEP Is a Highly Specific Target for Detection of Mycobacterium leprae

por Braet, S., Vandelannoote, K., Meehan, C. J., Brum Fontes, A. N., Hasker, E., Rosa, P. S., Lucena-Silva, N., Rigouts, L., Suffys, P. N., De Jong, B. C.
Publicado 2018

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment()

por Driesen, M., Kondo, Y., de Jong, B.C., Torrea, G., Asnong, S., Desmaretz, C., Mostofa, K.S.M., Tahseen, S., Whitfield, M.G., Cirillo, D.M., Miotto, P., Cabibbe, A.M., Rigouts, L.
Publicado 2018

Specific gyrA gene mutations predict poor treatment outcome in MDR-TB

por Rigouts, L., Coeck, N., Gumusboga, M., de Rijk, W. B., Aung, K. J. M., Hossain, M. A., Fissette, K., Rieder, H. L., Meehan, C. J., de Jong, B. C., Van Deun, A.
Publicado 2016

Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Miss...

por Ardizzoni, E., Ariza, E., Mulengwa, D., Mpala, Q., de La Tour, R., Maphalala, G., Varaine, F., Kerschberger, B., Graulus, P., Page, A. L., Niemann, S., Dreyer, V., Van Deun, A., Decroo, T., Rigouts, L., de Jong, B. C.
Publicado 2021